Mammograms versus ultrasound which screening test catches what

Mammography and ultrasound are different breast-imaging tests, not interchangeable screening options. Mammography uses low-dose X-rays and is the standard screening test for most people at average risk; it can detect cancers and precancerous changes such as calcifications that ultrasound may miss. Ultrasound uses sound waves and can help evaluate a lump or clarify a finding, and adding it to mammography may find some cancers in people with dense breasts—but it also leads to more false alarms and biopsies. The right approach depends on age, breast density, personal risk, symptoms, and local clinical guidance. The American Cancer Society estimates that about 1 in 8 U.S. women will develop invasive breast cancer during their lifetime, making it important to understand what each test can and cannot detect.

Mammography and ultrasound: what each test detects

Mammography is breast imaging performed with X-rays, usually in two views of each breast during routine screening. Ultrasound creates images using high-frequency sound waves and is commonly used as a targeted diagnostic test. The American College of Radiology describes mammography as the primary screening method for most women at average risk, while ultrasound is used mainly to investigate symptoms or supplement imaging in selected circumstances.

The distinction matters: a screening test looks for disease in people without symptoms, while diagnostic imaging investigates a symptom or an abnormal screening result. A person with a new lump should seek clinical assessment rather than choosing a screening test on their own.

What mammography is especially good at finding

Mammography can reveal masses, distortions in breast tissue, and tiny calcium deposits called microcalcifications. Some clusters of microcalcifications are associated with ductal carcinoma in situ (DCIS), a non-invasive breast cancer that may not form a lump and may not be visible on ultrasound. Mammography can also show changes over time by comparing current images with earlier studies.

Mammograms use a small amount of ionizing radiation. The U.S. Food and Drug Administration regulates mammography facilities, and the National Cancer Institute notes that screening mammography can find cancers before they are large enough to be felt. It can still miss cancers, particularly when dense tissue makes the image harder to interpret.

What ultrasound is especially good at finding

Ultrasound is useful for distinguishing a fluid-filled cyst from a solid mass and for examining a specific area that feels abnormal or looks uncertain on a mammogram. It can help guide a needle during a biopsy. Because it does not use ionizing radiation, it is also useful in many diagnostic situations during pregnancy, when a clinician may choose imaging based on the patient’s circumstances.

Ultrasound is not a reliable replacement for screening mammography. It may not show calcifications or some forms of early cancer, and its results can depend on the operator and the area examined. A normal ultrasound therefore does not necessarily rule out cancer or eliminate the need for mammography when mammography is recommended.

Breast density changes how mammography and ultrasound perform

Breast density describes the proportion of fibrous and glandular tissue compared with fatty tissue on a mammogram; it is not a measure of firmness or a symptom a person can reliably assess by touch. The American College of Radiology’s BI-RADS system classifies breast composition from almost entirely fatty to extremely dense. Dense tissue is common and is associated both with reduced mammogram sensitivity and with a higher risk of breast cancer.

Why dense breasts can obscure mammographic findings

Dense tissue and many cancers both appear white on a mammogram, so an abnormality can be harder to see against the background. The National Cancer Institute reports that approximately half of women aged 40 and older have dense breasts. Density is only one part of risk, however; age, family history, genetic factors, and personal medical history also matter.

What supplemental ultrasound may add—and what it may cost

In some people with dense breasts, ultrasound after a negative mammogram can reveal additional cancers that were hidden by dense tissue. The trade-off is more false-positive findings: areas that look concerning but are not cancer, prompting extra imaging or sometimes biopsy. The U.S. Preventive Services Task Force’s 2024 recommendation concluded that evidence was insufficient to determine the overall balance of benefits and harms of supplemental ultrasound or MRI after a negative mammogram in people with dense breasts.

That “insufficient evidence” finding is not a recommendation against supplemental imaging for every individual. It means the available evidence does not establish that the benefits outweigh the harms for the population as a whole. A clinician can consider density alongside a person’s overall breast-cancer risk and preferences.

Screening recommendations depend on age and risk

There is no single schedule that fits everyone. Guidelines differ because organizations weigh evidence and screening harms differently. For example, the U.S. Preventive Services Task Force recommends biennial mammography for women aged 40 through 74 at average risk. The American Cancer Society offers a different schedule: women aged 40 to 44 may choose annual screening, women aged 45 to 54 should have annual mammograms, and women 55 and older may switch to every-other-year screening or continue annually.

These recommendations apply to screening, not evaluation of symptoms, and may not fit people with a history of breast cancer, prior high-dose chest radiation, certain genetic variants, or a strong family history. People at higher risk may need earlier or additional screening, often including MRI; ultrasound is not automatically the preferred supplemental test. Discuss an individualized plan with a qualified clinician.

Screening versus diagnostic imaging

Screening mammography is scheduled for someone without breast symptoms. Diagnostic mammography uses additional views to investigate a symptom or an earlier finding, and may be paired with targeted ultrasound. For a new lump, nipple discharge, skin change, or other persistent breast change, contact a healthcare professional promptly; the appropriate imaging depends on age, pregnancy status, examination findings, and clinical history.

Higher-risk screening and individualized decisions

People with a substantially elevated lifetime risk may be advised to have annual MRI in addition to mammography. The American Cancer Society recommends annual MRI and mammography for certain high-risk groups, including people with a lifetime risk around 20% to 25% or greater based mainly on risk-assessment models. Ultrasound may be considered in some situations, but it does not provide the same information as MRI or mammography. A formal risk assessment can help guide the decision.

Benefits, limitations, and practical choices

Mammography has the strongest role as population screening because it can detect cancers and calcifications before symptoms appear and has evidence supporting routine use in recommended age groups. Its limitations include missed cancers, false-positive callbacks, and exposure to a low dose of radiation. Ultrasound avoids radiation and can clarify certain findings, but its limitations include operator dependence, reduced ability to detect calcifications, and a greater chance of additional testing when used as a supplement.

A simple comparison

  • Mammography: Best-established routine screening test; detects masses, tissue changes, and many calcifications; uses low-dose X-rays.
  • Ultrasound: Often useful for evaluating a specific lump or clarifying a finding; distinguishes many cysts from solid masses; uses sound waves rather than radiation.
  • Supplemental ultrasound: May detect some cancers not seen on mammography in dense breasts; also increases false alarms and follow-up procedures.
  • Neither test alone: Can guarantee that breast cancer is absent. Symptoms and risk history still require clinical attention.

Questions to ask before choosing additional imaging

Ask whether the appointment is for screening or diagnosis, whether your mammogram shows dense tissue, and how your personal and family history affect your risk. If supplemental imaging is proposed, ask what additional cancers it may detect, how often it leads to callbacks or biopsy, whether MRI is appropriate, and what insurance may cover. The decision should reflect both potential benefit and the possibility of unnecessary follow-up.

Conclusion: mammography remains the screening foundation

Mammography and ultrasound catch different findings. Mammography is the established screening foundation and is particularly valuable for detecting calcifications and changes that may not form a palpable lump. Ultrasound is especially useful for evaluating a targeted concern and may add detection in some dense breasts, but it can also generate false positives and does not replace mammography. Follow the screening schedule appropriate to your age and risk, discuss breast density and supplemental imaging with a clinician, and seek prompt evaluation for a new or persistent breast change.

Sources: American Cancer Society, Breast Cancer Facts & Figures 2024–2025, https://www.cancer.org/research/cancer-facts-statistics/breast-cancer-facts-figures.html; American Cancer Society, Recommendations for the Early Detection of Breast Cancer, https://www.cancer.org/cancer/types/breast-cancer/screening-tests-and-early-detection/american-cancer-society-recommendations-for-the-early-detection-of-breast-cancer.html; American College of Radiology, ACR Appropriateness Criteria: Supplemental Breast Cancer Screening Based on Breast Density, https://acsearch.acr.org/docs/ hava; National Cancer Institute, Breast Cancer Screening, https://www.cancer.gov/types/breast/screening; U.S. Preventive Services Task Force, Breast Cancer: Screening, https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening; U.S. Food and Drug Administration, Mammography Quality Standards Act and Program, https://www.fda.gov/radiation-emitting-products/mammography-quality-standards-act-and-program.